Biogen Idec Presents 2012 Strategic Priorities at 30th Annual J.P. Morgan …MarketWatch (press release)Continuing to advance the daclizumab Phase 3 program in MS. — Drive innovation and grow early-stage pipeline by: — Building world-class scientific…
India emerging as key centre for clinical trials for paediatric cancer drugspharmabiz.comIt is the Monoclonal antibodies(MABs) like Rituximab, oral targeted therapy like Imatinib and other newer drugs which are being used in clinical trials to improve …
Transplant Does Not Improve Survival in Follicular LymphomaMedscapeAn accompanying editorial notes that HDC–ASCT is "a powerful treatment for patients with follicular lymphoma," and suggests that in the current rituximab era, it should be r…
'Best Results' Yet for Poor-Prognosis Elderly With DLBCLThe Oncology ReportSAN DIEGO – Stretching out the delivery of rituximab significantly improved overall and event-free survival among older patients with poor-prognosis diffuse large B-ce…
High-dose chemotherapy, autologous stem cell transplantation failed to improve …HemOncTodayPatients received rituximab (Rituxan; Genentech, Idec Pharmaceuticals) in both arms during induction treatment in two of the trials. Median follow-up was up to…
MedIndiaOverall Survival in Follicular Lymphoma Patients Not Improved by Autologous …MedIndiaIn an accompanying editorial, Caron A. Jacobson and Dan L. Longo, MD, at the Department of Medicine at Brigham and Women's Hospital in Boston, write that…
Renewed Interest in Ibritumomab for Non-Hodgkin's LymphomaMedscapeBefore the new FDA ruling, the bioscan protocol required patients to receive an infusion of rituximab on day 1, which was followed by a diagnostic dose of radiolabeled indium-111 [ib…
ECTRIMS/ACTRIMS, Teil 2: Experimentelle MS-Therapien in der PipelineDMSG Multiple Sklerose NachrichtenDaclizumab – Die Phase II SELECT Studie untersuchte monatliche, unter die Haut verabreichte Injektionen eine niedrigen (150mg) und einer hohen (300m…
Rituxan Prolongs HIV-Related Lymphoma SurvivalAIDSmeds.com HIV/AIDS Treatment NewsFor people diagnosed with AIDS-related lymphomas, adding Rituxan (rituximab) to standard chemotherapy has a major positive effect on survival, according to new German coh…
Presentations Highlight Results of Clinical Data for MLN8237 and VELCADE(R) in …MarketWatch (press release)Also presented were biomarker data from a phase 3 study comparing VELCADE(R) (bortezomib) and rituximab (VcR) to rituximab (R) alone in patient…